Developer of a streamlined assay platform designed to reduce the time and cost for quantifying proteins for proteomic and pharmaceutical applications. The company's platform provides multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation, enabling researchers to access large panel protein studies as well as reduces the cost and time to market for candidate drug compounds.
The company raised venture funding from Pallasite Ventures on an undisclosed date. Prior to that, the company joined Y Combinator as part of its Winter 2018 Class on March 19, 2018 and received $120,000 in funding.
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.